News

News
Partner news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story
Partner news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story
Partner news

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story
Partner news

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story
In the media

Driving Innovation In UK Life Sciences

Read full story
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story
Partner news

CVRx Raises $50 Million in New Equity Financing

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
Partner news

HistoSonics Announces $40 Million Financing

Read full story
Partner news

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story